JoVE - Journal of Visualized Experiments
JoVE Visualize
Contact Us

Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study

  • 0Department of Preventive and Social Medicine, University of Otago, Dunedin, New Zealand. margaret.mccredie@otago.ac.nz
The Lancet. Oncology +

|

April 15, 2008

|

April 15, 2008

Related Experiment Videos

Contact us if these videos are not relevant.

View abstract on PubMed

Summary

This summary is machine-generated.

Untreated cervical intraepithelial neoplasia 3 (CIN3) significantly increases the risk of invasive cervical cancer. Conventional treatment of CIN3 dramatically reduces this risk, highlighting the importance of timely intervention for this precancerous condition.

Area Of Science

  • Gynecologic Oncology
  • Pathology
  • Epidemiology

Background

  • Cervical intraepithelial neoplasia 3 (CIN3) is a precancerous condition with poorly defined invasive potential.
  • An unethical study in New Zealand withheld treatment for CIN3 in some women between 1965-1974, creating a unique cohort for long-term risk assessment.
  • A judicial inquiry in 1988 prompted a review of management for women with CIN3, enabling comparison of outcomes based on treatment adequacy.

Purpose Of The Study

  • To estimate the long-term risk of invasive cervical cancer in women with CIN3 based on the adequacy of their initial management.
  • To compare the incidence of invasive cervical cancer in women with minimally disturbed CIN3 versus those receiving adequate initial treatment and conventional follow-up.

Main Methods

  • Retrospective review of medical records, cytology, and histopathology for women diagnosed with CIN3 between 1955-1976.
  • Inclusion of women whose treatment was reviewed by a judicial inquiry and whose records were locatable.
  • Linkage with cancer and death registers and electoral rolls for long-term outcome tracking until December 31, 2000.

Main Results

  • In 143 women treated only with biopsy, the 30-year cumulative incidence of invasive cancer was 31.3%.
  • In a subset of 92 women with persistent disease within 24 months, the 30-year incidence rose to 50.3%.
  • Conversely, in 593 women with adequate initial treatment and conventional management of recurrence, the 30-year cancer risk was only 0.7%.

Conclusions

  • This study provides robust estimates of CIN3 progression to invasive cancer.
  • Untreated or inadequately treated CIN3 carries a substantial risk of progression to invasive cervical cancer.
  • Conventional and timely treatment of CIN3 is highly effective in preventing invasive cervical cancer.

Related Experiment Videos

Contact us if these videos are not relevant.

Related Concept Videos